PATENT CLAIM ANALYSIS

Application Number: 16100424
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "315000"]

Abstract:
The methods disclosed herein relate to the treatment of chronic inflammatory dermal disorder in humans, by administering a therapeutically effective amount of RS-norketotifen.

Claim (Index 1):
A method for treating a chronic inflammatory dermal disorder in a human patient in need thereof, comprising orally administering to the human patient a therapeutically effective amount of 0.5 to 20 mg of RS-norketotifen or a pharmaceutically acceptable salt thereof dosed once or more daily, wherein administration is three or more consecutive days of administration, wherein the therapeutically effective amount of norketotifen or a pharmaceutically acceptable salt thereof does not produce sedative side effects in the human patient, and wherein the amount of said RS-norketotifen is calculated as free base.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15071546', '13739090', '14025302', '12378231', '11796998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7675054988843784
- 35 USC 102 Novelty (BERT): 0.505105004474102
- Combined Prediction Score: 0.7412654494433508
- Mean Citation Score: 265.179812
- Max Citation Score: 287.68826
- Similarity Product: 230.616253327446

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test